Highlights

A Quarter Century after the Human Genome Project's Launch presents: Dr. David Bentley

David Bentley On Thursday, May 26th, the NHGRI History of Genomics Program will complete its six-part seminar series featuring scientists who helped launch the Human Genome Project. David Bentley, D.Phil., Illumina's vice president and chief scientist of DNA Sequencing, will be the featured speaker. Dr. Bentley was a driving force behind the Sanger Centre's immense contributions to the Human Genome Project, prior to joining Illumina.
Read more about the series
Read about Dr. David Bentley

Genome: Unlocking Life's Code heads southwest

Logo for Genome: Unlocking Life's Code It's on the move again. On May 21, Genome: Unlocking Life's Code, NHGRI's genomics exhibit, created in partnership with the Smithsonian's National Museum of Natural History, is headed to the Natural History Museum of Utah in Salt Lake City. Now traveling on a five-year, multi-city tour, the exhibit challenges visitors to explore the fascinating world of genome science through high-tech, hands-on learning. For a limited time only! See it there before Sept. 5! Read more

Mouse models of Zika in pregnancy show how fetuses become infected

Mosquito A new mouse model of Zika virus infection in pregnancy is offering clues about how the virus works. Researchers at Washington University School of Medicine in St. Louis showed that the virus migrated from the pregnant mouse's bloodstream into the placenta, eventually infecting, and causing cell death, in the brains of the unborn pups. Using this mouse model, researchers hope to learn about the virus' biology and develop new vaccines and treatments. The research, co-funded by NHGRI, appears in Cell. Read the research | Read the press release

The Genomics Landscape

The Center for Inherited Disease Research at Twenty

Eric Green For this issue of The Genomics Landscape, I am delighted to feature the Center for Inherited Disease Research, which was founded in 1996. This month's issue also highlights the USA Science and Engineering festival, the Undiagnosed Diseases Network, a new online atlas of human malformation syndromes in diverse populations, and a recent virtual scientific meeting.
Read more

Quantifying the benefits and risks of psychostimulant medication for ADHD

A D H D methylphenidate written on a blackboard Establishing the benefits and possible risks of psychostimulant medication as a treatment for childhood Attention Deficit Hyperactivity Disorder (ADHD) is vital, says Philip Shaw, M.D., Ph.D., a researcher with NHGRI's Social and Behavioral Research Branch. His review of a recent meta-analysis on the use of the psychostimulant methylphenidate for ADHD appeared in the Journal of the American Medical Association (JAMA) and is the subject of a JAMA podcast.
Read the editorial

View Highlights Archive

Get Email Updates
Sign up for all the latest from NHGRI.

Newsroom
GenomeTV
 
Quick Links